EconBiz - Find Economic Literature
    • Logout
    • Change account settings
  • A-Z
  • Beta
  • About EconBiz
  • News
  • Thesaurus (STW)
  • Academic Skills
  • Help
  •  My account 
    • Logout
    • Change account settings
  • Login
EconBiz - Find Economic Literature
Publications Events
Search options
Advanced Search history
My EconBiz
Favorites Loans Reservations Fines
    You are here:
  • Home
  • Search: person:"O'Mahony, Rachel OMahony"
Narrow search

Narrow search

Year of publication
Subject
All
Celecoxib 1 Cost-utility 1 Cyclo-oxygenase-2-inhibitors 1 Diclofenac 1 Etoricoxib 1 Ibuprofen 1 Naproxen 1 Nonsteroidal-anti-inflammatories 1 Osteoarthritis 1 Proton-pump-inhibitors 1 Value-of-information-analysis 1 therapeutic use 1 treatment 1
more ... less ...
Online availability
All
Undetermined 1
Type of publication
All
Article 1
Language
All
Undetermined 1
Author
All
Conaghan, Philip G. 1 Dickson, John 1 Grant, Robert L. 1 Latimer, Nicholas 1 Lord, Joanne 1 O'Mahony, Rachel OMahony 1
Published in...
All
PharmacoEconomics 1
Source
All
RePEc 1
Showing 1 - 1 of 1
Cover Image
Value of Information in the Osteoarthritis Setting: Cost Effectiveness of COX-2 Selective Inhibitors, Traditional NSAIDs and Proton Pump Inhibitors
Latimer, Nicholas; Lord, Joanne; Grant, Robert L.; … - In: PharmacoEconomics 29 (2011) 3, pp. 225-237
Background: Recent National Institute for Health and Clinical Excellence (NICE) guidance recommended that when traditional NSAIDs or cyclo-oxygenase (COX)-2 selective inhibitors are used by people with osteoarthritis (OA), they should be prescribed along with a proton pump inhibitor (PPI)....
Persistent link: https://www.econbiz.de/10011005081
Saved in:
A service of the
zbw
  • Sitemap
  • Plain language
  • Accessibility
  • Contact us
  • Imprint
  • Privacy

Loading...